In this abstract, I will explain the specifics of my research and a detailed outline of my paper. Understanding the topic of medical fraud and off labeling is important, especially for consumers who participate in the use of prescription drugs. It is imperative to understand what your doctor is prescribing and knowing the specific uses of said drug. Off labeling may occur and recognizing this fact will only benefit a wise consumer and make them aware of the risks of using a drug that was prescribed for a uses not on the label. This topic is especially important during the time of new Healthcare reform. Although it seems like we should be able to trust our doctors and believe what they tell us and the drugs they approve for us to use, we have the responsibility to check their credibility and research the drugs on our own. When we don't look for specifics about pharmaceutical drugs, we are at risk of being hurt with side effects. Because the doctors are allowed to prescribe an approved drug for anything, as long as the FDA clears it, we can be fooled into believing it was made for a specific ailment. Also, the doctors are not required to tell the specifics of a drug, we can only be responsible for knowing that ourselves. The problem this topic addresses is the reality that major pharmaceutical companies are committing fraud to fool consumers. Recognizing that what they are participating in is fraud shed's a light on what we should be questioning. It also includes understanding the role of the FDA and how effective their laws are. Witnessing crack downs on major companies on behalf of the consumer, and the penalties administered, makes us believe that our government, in some ways, is looking out for our best interest. I believe bringing this fraud into the light is the start of a change. The more consumers hear about big cases, like that of Pfizer, the more they can begin to question. The purpose of this paper is to talk about the awareness while explaining the facts. The methods of approach used to address this topic are clarifying what off labeling is and a brief history of medical fraud and quackery, describing the Food and Drug Administration and their roles in eliminating fraud in major pharmaceutical companies, and citing the case of Pfizer to show a specific example of what off labeling fraud looks like. I have come up with several key findings in my research of off labeling and medical fraud. First, medical fraud is something that can be committed in all levels of the medical/ healthcare industry. While doctors, at a lower level, may have the ability to prescribe drugs off label, they are still not being completely truthful when doing so. Keeping information from the consumer doesn't seem to be an attribute one would be pleased to discover in the doctors they want to trust. On a much larger level, pharmaceutical companies commit fraud when they try and push the marketing of a drug they know can be used to different uses than what was approved by the FDA. This in fact is illegal, but knowing that fact, they still seem to see that the reward could be greater than the risk. The conclusions that stem from my findings in this paper, are like I previously stated; the importance of being aware of what prescriptions are given and the specifics about a drug, the benefits of knowing what the FDA does and how it effects us daily, and how to recognize fraud in the major pharmaceutical companies and what can and is being done to stop and prevent such actions.
Medical fraud has been around as long as medicine has existed. It was not until early in the twentieth century that there was much difference between the practices of mainstream medicine and quacks. Medicine made from unknown natural oils and such were passed off to have healing attributes while containing nothing of the sort. People are inclined to spend their money on anything they believe will make their quality of life better, and anyone who...
References: Evans, D. (n.d.). Pfizer Broke the Law by Promoting Drugs for Unapproved Uses - Bloomberg.com. Bloomberg.com. Retrieved April 2, 2010, from http://www.bloomberg.com/apps/news?pid=20601202&sid=a4yV1nYxCGoA
FindLaw&, t. B. (n.d.). FindLaw 's Common Law: Pfizer 's 'Off-Label ' Marketing of Bextra Draws Record Breaking Fines. FindLaw 's Common Law. Retrieved April 2, 2010, from http://commonlaw.findlaw.com/2009/09/pfizers-offlabel-marketing-of-bextra-draws-record-breaking-fines.html
Just what does the FDA do, anyway? | Seattle/LocalHealthGuide. (n.d.). Seattle Local Health Guide. Retrieved April 2, 2010, from http://localhealthguideonline.com/just-what-does-the-fda-do-anyway/
Lawrence, D. (n.d.). Off-Labeling: A Major Pharmaceutical Issue - Levick Strategic Communications. Levick Strategic Communications - High-Stakes PR, Crisis Management & Communications Firm. Retrieved April 1, 2010, from http://www.levick.com/resources/topics/issues/offlabeling.php
Vucci, E., & AP. (n.d.). Pfizer fined $2.3 billion for illegal marketing in off-label drug case - USATODAY.com. News, Travel, Weather, Entertainment, Sports, Technology, U.S. & World - USATODAY.com. Retrieved March 25, 2010, from http://www.usatoday.com/money/industries/health/2009-09-02-pfizer-fine_N.htm
Please join StudyMode to read the full document